healthcaretrends

What are the Global Growth Factors?

Growth in the point of care molecular diagnostics market is mainly driven by factors such as the increasing worldwide prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests.

What The Experts Says about the Market Growth?

The global point of care molecular diagnostics market is expected to reach USD 1440.2 Million by 2023 from USD 725.5 Million in 2018, at a CAGR of 14.7%.

Browse and in-depth TOC on "Point of Care Molecular Diagnostics Market"

68 – Tables
23 – Figures
106 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127

Global Market Segmentation:

On the basis of product & service, the market is broadly segmented into assays & kits, instruments/analyzers, software & services. The assays & kits segment is expected to hold the largest share of the market in 2018 and is also projected to grow at highest CAGR in the global POC molecular diagnostics market during the forecast period.

On the basis of technology, the market is broadly segmented into RT-PCR, INAAT, and other technologies. The RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market in 2018. RT-PCR is a highly cost-effective and preferred technology for POC settings that allows for the concurrent monitoring of expression levels of multiple genetic messages. Such benefits are driving the growth of the RT PCR segment.

On the basis application, the market is broadly segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, herpes simplex virus, Ebola, Zika virus).

On the basis of end users, the market is broadly segmented into physician offices, hospital EDs and ICUs, research institutes, and other end users. The physician offices segment is expected to hold the largest share of the market.

Geographical Analysis of Point of Care Molecular Diagnostics Market:

North America is expected to account for the largest share of the global POC molecular diagnostics market. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives to support the adoption of POC molecular diagnostics in this region are driving the market growth.

Get Your Queries Resolved From Subject Expert | Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=143524127

Key Market Players:

Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market.

What is the future growth analysis of global Bio Decontamination Market?

The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1%

What are key factors driving growth of global Bio Decontamination Market?

The rising incidence of hospital-acquired infections (HAIs), growth in the pharmaceutical and biotechnology industries, and increasing outsourcing of bio decontamination services are factors driving the growth of the bio decontamination market.

What the growth opportunities are in Bio Decontamination Market?

1. Untapped Emerging Markets
2. Growth in the Pharmaceutical and Biotechnology Industries

Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777   

Global Market Segmentation:

In the current market scenario, there is a growing demand for bio decontamination. The market has been categorized based on the product, type, end user and region.

On the basis of product & service, the bio decontamination market is segmented into equipment, consumables, and services. In 2018, the equipment segment accounted for the largest market share of bio decontamination industry. The launch of new and advanced instruments, portability, and the reduced need for manual intervention are key factors driving the growth of this segment.

By type, the bio decontamination industry is segmented into room and chamber bio decontamination. In 2018, chambers accounted for the largest share of the market. The large share of this segment can be attributed to factors such as lower power consumption, smaller footprint, and cost-effectiveness.

On the basis of agent type, the bio decontamination market is segmented into hydrogen peroxide, nitrogen dioxide, chlorine dioxide, and peracetic acid. In 2018, the hydrogen peroxide segment accounted for the largest share of the bio decontamination industry. The advantages offered by hydrogen peroxide, such as material compatibility and safety with minimum residue, are the major factors contributing to its dominance in the bio decontamination industry.

On the basis of end user, the biodecontamination market is segmented into pharmaceutical & medical device manufacturing companies, hospitals & healthcare facilities, and life sciences & biotechnology research organizations. In 2018, the pharmaceutical & medical device manufacturing companies segment accounted for the largest market share and highest growth rate, owing to the growing adoption of biodecontamination products & services by pharmaceutical and medical device manufacturing industries to adhere to stringent regulations.

Geographic Growth Analysis:

On the basis of region, the bio decontamination market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the bio decontamination industry. The large share of this regional segment can be attributed to the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections and the presence of major players in the region.

Get Your Queries Resolved From Subject Expert | Speak To Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=104696777

Key Players In Global Bio Decontamination Market:

The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).

The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0%. An increasing number of RNA-seq grants, advantages of RNA-seq over conventional technologies, rapid growth in precision medicine market clubbed with a growing number of research activities involving RNA-seq are the key factors driving the growth of the NGS-based RNA-sequencing industry.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816

Based on product & service, the market is segmented into sample preparation products, RNA sequencing platforms & consumables, RNA sequencing services, and data analysis, storage, and management. In 2018, the RNA sequencing platforms & consumables segment accounted for the largest share of the NGS-based RNA-sequencing market. This can be attributed to the ongoing technological advancements in the market and the increasing availability of innovative & cost-effective sequencing platforms.

Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. In 2018, the largest NGS-based RNA-sequencing market share was held by the sequencing by synthesis segment. The large share of this segment is attributed to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology.

By region, the NGS-based RNA-sequencing industry is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. The market in Asia Pacific is projected to register the highest CAGR during the forecast period. Significant focus on R&D activities as a means of broadening the scope of RNA-Seq applications and decreasing the costs of NGS products and services are some of the key factors supporting the growth of the NGS-based RNA-sequencing market in the Asia Pacific.

What is the Future Growth Analysis of Physiotherapy Equipment Market?

The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from US 15.0 billion in 2018, at a CAGR of 5.8%.

What are the Key Factors Driving Growth in Physiotherapy Equipment Market?

The growth of this market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease.

What are the latest Opportunities and Challenges in the Global Physiotherapy Equipment Market?

Opportunities:
1. Emerging Markets
2. Technological Advances

Challenges:
1. Shortage of Skilled Personnel
2. Alternative therapies Such as Acupuncture

Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228

Global Market Segmentation:

In the current market scenario, there is a growing demand for physiotherapy equipment. The market has been categorized based on product, application and region.

The electrotherapy equipment segment is projected to hold the largest share of the market, during the forecast period. The large share of the segment is primarily attributed to the by rapid adoption electrical stimulation-based techniques in rehabilitation.

Transcutaneous Electrical Nerve Stimulation, Functional Neuromuscular Stimulation, H-wave Stimulation, Neuromuscular Electrical Stimulation, Interferential Stimulation, Microcurrent Stimulation, Galvanic Stimulation, Sympathetic Therapy, Peripheral Subcutaneous Field Stimulation, Peroneal Nerve Stimulation, and Auricular Stimulation (P-stim).

On the basis of application, the market is segmented into cardiovascular and pulmonary applications, musculoskeletal applications, neurological applications, pediatric applications, gynecological applications, and other applications (includes sports and palliative care). In 2018, the musculoskeletal applications segment accounted for the largest share of the market, followed by the neurological applications segment. The large share of the musculoskeletal applications segment is attributed to the rising incidence of musculoskeletal disorders, growth in the geriatric population, and the increasing number of accidents.

Geographical Growth Analysis Of Global Physiotherapy Equipment Market:

The physiotherapy equipment market is predominantly divided into four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of this market, followed by North America. The major drivers for the growth of this market are the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms. However, an uncertain reimbursement scenario and the need for reforms in physiotherapy educational practices are hindering the growth of this market.

Key Market Players:

Major vendors in the physiotherapy equipment market include DJO Global (US), Performance Health (US), BTL Industries (US), and EMS Physio (UK).

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65250228

What are the Recent Developments in The Physiotherapy Equipment Market?

1. In 2018, DJO entered into a strategic partnership with XPO Logistics, to manage portions of DJO’s North American distribution operations.

2. In 2017, Dynatronics partnered with Orthopedic Outfitters to distribute Dynatronics’ physiotherapy and rehabilitation products.

Key Information Addressed in Research Study:

1. Who are the major market players in the physiotherapy equipment and accessories market?

2. What are the growth trends and the largest revenue-generating region for physiotherapy equipment?

3. How are physiotherapy equipment sold to customers?

4. What are the major types of physiotherapy equipment and accessories?

5. What are the driving, restraining, opportunistic, and challenging factors for this market?

Biosurgery Market:

The overall biosurgery market is expected to grow from $10.67 billion in 2017 and is expected to grow at a CAGR of 6.5% during the forecast period, to reach $15.58 billion by 2023.

What are the key market growth factors?

1. Rising geriatric population
2. Increasing volume of surgeries and prevalence of severe trauma injuries
3. Strong focus on R&D leading to the launch of new and advanced products
4. Rising need for effective blood loss management in patients

The biosurgery market is expanding with the emergence of new products and applications. These biosurgery product being used in many applications such gynecological surgery, general surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, urological surgery, reconstructive surgery and thoracic surgery.

Increasing Use of Biosurgery Products in Surgical Producers:

Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones. Some commonly used biosurgery products include Surgical Sealants and adhesives, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple line reinforcement agents.

These products are intended to control blood loss, aid wound healing, and assist the healing of surgical sites during various surgeries. Therefore, the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities, and growing need for effective blood loss management in patients drives the growth of market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302

Application of Biosurgery Market:

Orthopedic surgeries is one of those applications where the procedures are associated with significant blood loss owing to the dissection of bony and fibrotic tissues.

Gynecological procedures such as myomectomies (surgical removal of uterine fibroids without the removal of the uterus), hysterectomies (surgical removal of the uterus), and surgeries for C-section requires biosurgery products.

Biosurgery products are used in surgical procedures performed for the treatment of diseases involving the skin, soft tissues, and hernias. Of these, hernia repair, for inguinal, umbilical, hiatal, femoral, and incisional hernias, among other types, are among the most common.

Biosurgery products for cardiovascular surgeries include coronary artery bypass grafting (CABG), congenital heart surgery, aortic anastomosis during CABG, and implantation of vascular prostheses.

Technological Innovations in Biosurgery Products Opening New Avenues For Growth In Biosurgery Market.

Target Audience:

1. Biosurgery product manufacturers
2. Biosurgery product distributors and suppliers
3. Healthcare providers
4. Medical device manufacturers
5. Research institutes and academic centers
6. Contract research organizations (CROs)
7. Government associations
8. Market research and consulting firms
9. Venture capitalists and investors

Key Players in Market:

The biosurgery market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the market are Baxter International (US), C.R. Bard (US), Johnson & Johnson (US), Medtronic (Ireland), Sanofi (France), B. Braun (Germany), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Hemostasis (US), Integra Lifesciences (US), Cohera Medical (US), Pfizer (US), and CSL Limited (Australia).

Major Developments In Biosurgery Market:

1. Integra LifeSciences Holdings Corporation (US) launched the Codman Specialty Surgical product portfolio in April 2018.

2. Baxter International Inc. (US) enhanced its FLOSEAL and TISSEEL hemostatic product OFFERINGS in April 2017.

3. In September 2017, Medtronic launched the Infuse Bone Graft, which is a recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge carrier (ACS). It helps stimulate natural bone formation.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

The global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions.

What are the Global Growth Factors?

Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardiac muscle injury, and dental applications.

What is the future analysis of Plasma Therapy Market?

The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333

Global Market Segmentation:

The global market is segmented on the basis of type, source, application, end user, and region.

On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). The pure PRP segment is estimated to account for the largest share of the global market in 2016. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market.

On the basis of source, the market is segmented into autologous and allogenic. The autologous segment is estimated to account for the largest share of the global market in 2016. Awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues are driving the growth of the autologous source segment of the market.

Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology segment is expected to grow at the highest CAGR from 2016 to 2021, owing to the increasing number of dermatological disorders.

On the basis of end user, the market is classified into hospitals & clinics and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market in 2016. This large share is mainly attributed to rise in healthcare expenditure and increase in the use of PRP products in hospitals.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333

Geographical Analysis:

Geographically, the market is led by North America, followed by Europe, Asia-Pacific, and rest of the world (RoW). Growth in the global market is primarily driven by the increase in aging population and rise in the number of orthopedic disorders.

Target Audience of Plasma Therapy Market:

1. Platelet-rich Plasma (PRP) Manufacturers and Suppliers
2. Academic Research Institutes
3. Hospitals & Clinics
4. Research & Development (R&D) Companies
5. Business Research & Consulting Service Providers
6. Medical Research Laboratories
7. Academic Medical Centers & Universities

Key Players:

Major players operating in Plasma Therapy Market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland).

The global hybrid operating room market is projected to reach USD 1,174.9 million by 2022 from USD 652.0 million in 2017; growing at a CAGR of 12.5% during the forecast period. Factors such as technological advancements in the field of robot-assisted surgeries, increasing number of minimally invasive surgeries, and growing patient preference for affordable & effective surgical treatments are driving the growth of this market.

Ongoing technological advancements in the field of robot-assisted surgeries are expected to enable surgeons to perform surgical procedures with greater precision, accuracy, and shorter procedural time. The adoption of medical robots in a hybrid operating room setup is expected to rise during the forecast period. Moreover, recent advancements in the field of surgical treatments coupled with the advent of minimally invasive technologies have resulted in reduced hospitalization time, minimal patient injury, faster patient recovery, lower procedural costs, and higher therapeutic efficacy with lower chances of disease relapse (as compared to conventional procedures).

Based on components, the hybrid operating room market is segmented into intraoperative diagnostic imaging systems, operating room fixtures, surgical instruments, audiovisual display systems and tools, and other components.  The intraoperative diagnostic imaging systems segment is expected to grow the fastest (as compared to other component segments) owing to the increasing application horizons of hybrid operating rooms,  development of advanced diagnostic imaging systems (such as MRI, CT scaner, and angiography systems), and growing adoption of image-guided surgeries in effective disease management.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264471209

The global hybrid operating room market is segmented into cardiovascular, thoracic, neurosurgical, orthopedic, and other application segment. The thoracic applications segment is expected to grow at a fastest rate during the forecast period owing to the rising number of thoracic surgeries across the globe coupled with growing awareness of healthcare professionals towards the cost & therapeutic efficacy offered by hybrid ORs.

Moreover, the hybrid operating room market is further segmented by end user into hospitals & surgical centers and ambulatory surgical centers (ASCs). The hospitals and surgical centers is expected to grow faster as compared to ASCs owing to rising patient emphasis on timely and effective disease management, rising number of diagnostic and surgical procedures carried out at hospitals, and increasing number of hospitals and surgical centers being set up in developing countries (such as India, China, and South Africa) during the forecast period.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=264471209

The global neuroendoscopy devices market is expected to reach USD 218.9 million by 2022 from USD 170.5 million in 2017, at a CAGR of 5.1%. Factors such as favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgeries over conventional brain surgeries are driving the growth of this neuroendoscopy market. On the other hand, the high cost of neuroendoscopy procedures and equipment may hinder the growth of the market.

The neuroendoscopy market, by product, is segmented into rigid neuroendoscopes and flexible neuroendoscopes. In 2017, the rigid neuroendoscopes segment accounted for the largest share of the global neuroendoscopy devices market. This segment is also expected to grow at the highest CAGR during the forecast period. This large share and high growth can be attributed to the benefits of rigid neuroendoscopes such as superior optics, reusability due to autoclaving, and high device strength.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68126508

Based on application, the neuroendoscopy market is segmented into intraventricular neuroendoscopy, transcranial neuroendoscopy, and transnasal neuroendoscopy. The transcranial neuroendoscopy segment is expected to register the highest CAGR during the forecast period. The significant growth of this segment is owing to factors such as their wide application in the diagnosis and treatment of larger tumors with significant suprasellar extension and growing incidence of brain tumors.

Based on usability, the neuroendoscopy market is segmented into reusable and disposable neuroendoscopes. The reusable neuroendoscopes segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the cost-effectiveness of reusable devices as they can be used in multiple procedures after procurement.

Among the four regional segments covered in the neuroendoscopy market—North America, Europe, Asia, and the Rest of the World (RoW). Geographically, the neuroendoscopy devices market in the Asian region is expected to register the highest CAGR during the forecast period. Growth in this regional segment is largely driven by the increased spending on healthcare, presence of a huge population base, growing geriatric population, increasing medical tourism, and increasing prevalence of diseases in the region.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=68126508  

The medical terminology software market is projected to reach USD 1,786 million by 2024 from USD 707 million in 2019, at a CAGR of 20.4% during the forecast period. The growth in this market is driven by the rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations. The increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years. However, the reluctance to use terminology solutions over conventional practices will pose a major challenge to the growth of the medical terminology software market during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239939409

On the basis of application, the medical terminology software market is segmented into data aggregation, data integration, decision support, clinical guidelines, reimbursement, quality reporting, clinical trials, and public health surveillance. The quality reporting segment is expected to register the highest growth during the forecast period. The government focus on implementing regulations to encourage the adoption of quality reporting is a key factor driving the growth of this segment.

Based on product & service, the medical terminology software market is segmented into services and platforms. The platforms segment is expected to register the highest growth during the forecast period. Growth in this segment can be attributed to the rising demand for multi-tenancy systems among large enterprises and IDN networks.

Based on end user, the medical terminology software market is broadly segmented into healthcare providers, healthcare payers, healthcare IT vendors, and other end users. The healthcare providers segment is expected to register the highest growth during the forecast period. This can be attributed to the increasing demand for minimizing medical errors arising due to the incorrect interpretation of patient data.

Geographically, the medical terminology software market in the Asia Pacific is expected to witness the highest growth during the forecast period. Factors such as improving healthcare infrastructure, rising healthcare insurance coverage, and growing medical tourism in the region are driving the growth of the medical terminology software market in the Asia Pacific.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=239939409

The global medical terminology software market is consolidated, with a small number of companies continuously trying to mark their presence. They are focused on developing enhanced terminology solutions and diversifying their product portfolios to include every aspect of terminology management.

Over the last decade, the phototherapy equipment industry has witnessed significant technological advancements and robust product developments. The global phototherapy equipment market is projected to grow at a CAGR of 4.5% during the forecast period. Geographically, this market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

As of 2016, North America and Europe are expected to dominate the phototherapy equipment market. The dominant position of North America in this market can be attributed to the presence of a large end-user base, significant availability of public-private funding for research activities, faster adoption of advanced technologies, and growing number of phototherapy-based researches in the U.S. However, the Asia-Pacific phototherapy equipment market is expected to witness higher growth during the forecast period, majorly due to the strategic expansion of key players in emerging Asian countries, growing prevalence of skin diseases & neonatal jaundice, ongoing expansion of healthcare infrastructure by emerging countries (especially India and China), increasing medical tourism, and evolving regulatory scenario.

Due to the significant growth opportunities offered by emerging countries (India, China, Malaysia, and Taiwan), a number of vendors operating in the market have been focusing on expanding their presence in the Asia-Pacific region. Market players are also continuously focusing on the launch and promotion of products in these regions to gain a competitive advantage.

Where will all these developments take the industry in the mid to long term?
Know more, Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174360683  

Phototherapy equipment are being used in hospitals and clinics; home-use equipment have also been launched in the market. Hospitals & clinics account for a major share in the end-user market, whereas the home-use segment is expected to witness higher growth. In recent years, many companies have developed phototherapy equipment offering features such as integrated timers and automated calibration, which ensure the safety of patients. The launch of such advanced phototherapy equipment is expected to result in more number of prescriptions from doctors for home phototherapy.

A number of players operating in the phototherapy equipment market are focusing on product launches and enhancements as their key growth strategy to expand their product portfolios and revenues. As of 2015, key players operating in the phototherapy equipment market include GE Healthcare (U.K.), Philips Lighting Holding B.V. (Netherlands), Natus Medical Incorporated (U.S.), Phoenix Medical Systems Pvt. Ltd. (India), Herbert Waldmann GmbH & Co. KG (Germany), Atom Medical Corporation (Japan), nice Neotech Medical Systems Pvt. Ltd. (India), National Biological Corp. (U.S.), and Solarc Systems Inc. (Canada), among others.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174360683

The global plastic surgery instruments market is expected to reach USD 1.47 billion by 2023 from USD 1.00 billion in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers for the global plastic surgery instruments market.

The plastic surgery instruments market is segmented on the basis of type, procedure, end user, and region. By type, the market is segmented into handheld instruments, electrosurgical instruments, and other plastic surgery instruments. The electrosurgical instruments segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the factors such as technological advancements, new product launches, and the growing demand for reducing the operating time of surgeries.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=27952683

On the basis of procedure, the plastic surgery instruments market is segmented into cosmetic surgery and reconstructive surgery. The cosmetic surgery segment is further categorized into breast procedures, face & head cosmetic surgery, and body & extremities cosmetic procedures. The cosmetic surgery segment is expected to account for the largest share of the plastic surgery instruments market in 2018. The large share of this market segment can primarily be attributed to the high demand and growing public acceptance of cosmetic procedures, changing lifestyles, and growing willingness to spend on cosmetic surgeries across the globe.

Based on end user, the plastic surgery instruments market is segmented into hospitals and other end users. In 2018, the hospitals segment is expected to account for the largest share of the plastic surgery instruments market. Factors such as the growing patient pool, rising number of plastic surgery procedures in hospitals, rising prevalence of cancer, growing number of age-related cosmetic surgeries, increasing awareness of cosmetics surgeries, and improving healthcare infrastructure are driving the growth of this end-user segment.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=27952683

Among the four regional segments (North America, Europe, Asia, and RoW) covered in this report, Asia is expected to grow at the highest CAGR during the forecast period. The high growth rate of the region is attributed to factors such as the growing middle-class disposable income in emerging Asian countries, growing aging population and age-related cosmetic procedures, and increasing medical tourism in the region. The increasing focus of prominent players in Asia is also supporting market growth in the region.

The global immuno oncology assays market to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The rising incidence of cancer and increasing adoption of targeted therapy are the key factors driving the market. Companion diagnostics have been identified as an area of opportunity for companies seeking to develop innovative products or capabilities in the market.

Based on product, the immuno oncology assays market is segmented into consumables and software. The consumables segment accounted for the larger market share in 2018. The large share of this segment is attributed to the availability of a wide range of reagents and kits, increasing use of reagents in different oncology therapeutic treatments, increasing research on cancer immunotherapy biomarkers and its applications in drug development, and easy accessibility to a wide range of reagents.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166

Based on indication, the immuno oncology assays market is categorized into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers (leukemia, thyroid cancer, kidney cancer, multiple myeloma and CNS, gastric cancer, liver cancer, pancreatic cancer, oral and pharynx cancer, stomach cancer, and ovarian cancer). Of all these segments, the lung cancer segment accounted for the largest share in 2018. Growth in this market segment is largely driven by the rapidly increasing global prevalence of lung cancer and the increasing R&D activities on lung immuno-oncology assays.

In terms of geographical coverage, the immuno-oncology assays market has been segmented into four regions—North America, Asia Pacific (APAC), Europe, and RoW. The Asia Pacific is projected to record the highest growth rate during the forecast period. China, Japan, and India are the major markets for immuno-oncology assays in the Asia Pacific. With the increasing demand for better healthcare services in developing economies and accurate diagnostic tests from the large patient population, the Asia Pacific region is expected to provide significant growth opportunities for immuno-oncology assay manufacturers. This region is considered the most lucrative market for immuno-oncology assays owing to the large patient population, rising healthcare needs, increasing focus on improving the quality of laboratory testing, strategic developments by leading players, and the rapid growth in the number of accredited laboratories.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=52562166

“The endoscopy equipment market projected to grow at a CAGR of 6.6% during the forecast period (2019–2024).”

The global endoscopy equipment market is projected to reach USD 35.2 billion by 2024 from an estimated USD 25.6 billion in 2019 at a CAGR of 6.6% during the forecast period. The key factors driving the growth of this market include growing demand for endoscopy, growing investments, funds, and grants, rising number of hospitals, and increasing hospital investments in endoscopy facilities, and technological advancements. However, unfavorable healthcare reforms in the US and the high cost of endoscopy procedures & equipment and limited reimbursement in developing countries are expected to restrain the growth of this market.

“By application, the GI endoscopy segment is expected to grow at the highest CAGR during the forecast period (2019–2024).”

Based on application, the market is segmented into laparoscopy, gastrointestinal endoscopy, arthroscopy, obstetrics/gynecology endoscopy, urology, bronchoscopy, mediastinoscopy, ENT endoscopy, and other applications.

The GI endoscopy applications segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the rising geriatric population, improving healthcare infrastructure in developing countries, and the increasing number of colonoscopy procedures performed in developed countries.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689

“Asia Pacific (APAC) to witness the highest growth during the forecast period (2019-2024)”

Asia Pacific is expected to witness the highest growth from 2019 to 2024. The highest growth rate of the APAC market is attributed to universal healthcare coverage and the presence of a well-developed healthcare system in Japan, large patient population and healthcare infrastructure improvements in China, and rising medical tourism in India.

This report provides insights into the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the endoscopy equipment market. The report analyzes the market based on the product, application, and end-user

Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the endoscopy equipment market

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various endoscopy equipment across regions

Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the endoscopy equipment market

Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the endoscopy equipment market

Request Sample Pages of Global Market Analysis @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=689

The veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billon in 2019, at a CAGR of 8.4%. The growth of this market is driven by growing advancements in diagnostic devices, growth in the companion animal population, rising demand for pet insurance, growth in the number of veterinary practitioners in developed economies, and increasing disease control & disease prevention measures.

In this report, the global veterinary infectious disease diagnostics market has been segmented into technology, animal type, end-user, and region.  Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment is classified further into lateral flow assays, ELISA tests, and other immunodiagnostic products. The molecular diagnostics segment is divided further into PCR tests, microarrays, and other molecular diagnostics products.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584

The immunodiagnostics segment is expected to register the highest growth rate in the veterinary infectious disease diagnostics market during the forecast period. The higher preference for advanced infectious disease diagnostic products by veterinarians, animal farm owners, government institutions & organizations, pet owners, and laboratory technicians; growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.

Based on animal type, veterinary infectious disease diagnostics market is segmented into companion animals and food-producing animals. The animal segment is sub-segmented into viral, bacterial, parasitic, and other infections. In 2018, the companion animals segment accounted for the larger share of the veterinary infectious disease diagnostics market. Increasing pet ownership (especially in developed countries), growing penetration of pet insurance, rising number of veterinary practitioners globally, and the increasing animal disease control and disease prevention measures will continue driving the growth of this segment.

Based on end-user, the veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, research institutes & universities, and point-of-care/in-house testing. The reference laboratories segment was the largest end-user of the veterinary infectious disease diagnostics market in 2018. The large share of this end-user segment is mainly due to a large number of samples received for analysis in reference laboratories from small and large animal practices

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=221816584

 On the basis of region, the market is segmented into North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa. North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2018. Factors such as the increasing demand for prevention, early diagnosis & treatment of veterinary infectious disease diagnostics, growing pet insurance industry, rising veterinary healthcare expenditure, growing awareness of zoonotic diseases, and the growing number of veterinary practices are expected to drive the veterinary infectious disease diagnostics market in the region.

The fluid management systems market is projected to reach USD 12.47 billion by 2021 from USD 9.39 billion in 2016, at a CAGR of 5.8% during the forecast period. Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management systems, and increase in government funds and grants worldwide for endosurgical procedures are driving the fluid management systems market. Moreover, the untapped potential in emerging markets and rising use of single-use disposable devices and accessories are expected to offer growth opportunities for market players operating in the fluid management systems market.

The fluid management systems accounted the largest share of fluid management systems market in 2015. Within the fluid management systems, the integrated fluid management systems segment is expected to grow with the highest CAGR. Integrated systems are highly multifunctional and are mostly used to enable better and effective fluid management during critical surgical procedures.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153551158

The fluid management disposables and accessories segment is the fastest growing segment of the fluid management systems market during the forecast period. Rising usage of single-use disposable accessories and advancements in technologies are the factors driving this market. Furthermore, disposable accessories help reduce the risk of contamination from hazardous substances and ensure greater level of safety for patients and healthcare professionals. With these benefits, there is a growing trend towards the usage of disposable accessories to avoid risk of contamination due to body fluids and bloodborne pathogens and avoid further complications due to infections.

Within the application segment, laparoscopy segment is projected to grow at the highest CAGR in the forecast period. Factors such as rising prevalence of colorectal cancer, increasing use of laparoscopy for bariatric surgeries, and technological advancements in laparoscopic instruments are driving this market.

North America accounted for the largest share of the fluid management systems market in 2015, followed by Europe, Asia-Pacific, and the Rest of the World. However, Asia-Pacific is expected to grow with the highest CAGR and is expected to contribute a greater share in the global market in the coming years.  A number of factors, such as the rising geriatric population, increased patient awareness for minimally invasive endosurgeries, rapid rise in the number of people suffering from kidney disorders, growth in per capita income, increasing investments in the healthcare industry by key market players, rising demand of cutting-edge technologies in endosurgeries, and expansion of private-sector hospitals in rural areas are expected to drive the growth of the Asia-Pacific market during the forecast period.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153551158

Temperature management is the process of regulating a patient’s body temperature during a specific medical/surgical condition.

The global temperature management market to grow from USD 2.6 billion in 2019 to USD 3.0 billion by 2024, at a CAGR of 3.2% during the forecast period. Market growth is largely driven by the increasing global incidence of chronic conditions and the subsequent increase in the number of surgical procedures. The growing number of contracts and agreements between market players is also expected to offer a wide range of growth opportunities for market players during the forecast period.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141546773

Based on products, the temperature management market is segmented into patient warming systems and patient cooling systems. Of these two segments, patient warming systems accounted for the largest share of the temperature management market in 2018. The large share of this market segment can primarily be attributed to factors such as the growing demand for these systems in diverse hospital settings and the increasing adoption of invasive warming in surgical procedures such as orthopedic surgeries, gynecological & obstetric procedures, gastrointestinal procedures, and general surgeries.

Based on applications, the temperature management market is segmented into perioperative care, acute care, newborn care, and other applications. The perioperative care segment accounted for the largest share of the temperature management market in 2018. The increasing number of surgical procedures performed worldwide is the major factor driving the growth of this application segment. In addition, technological advancements, the increasing number of product launches for the perioperative care segment, and the growing number of partnerships between key market players and hospitals are also supporting market growth.

Based on medical specialty, the temperature management market is segmented into general surgery, cardiology, neurology, thoracic surgery, orthopedics, pediatrics, and other medical specialties (such as ophthalmic, ENT, bariatric, and cosmetic surgeries). The general surgery segment accounted for the largest share of the temperature management market in 2018. Surgeries of the breast, endocrine system, gastrointestinal tract, colon, liver, pancreas, uterus, and rectum are considered under the general surgery category. The rising incidence of cancers such as breast cancer, colorectal cancer, liver cancer, GI disorders, and endocrine disorders, and the increasing number of general surgical procedures are the major factors driving the growth of this segment.

The temperature management market is divided into four major regions North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America was the largest contributor to the global temperature management market, followed by Europe. The large share of this regional segment is mainly due to the large volume of surgical procedures performed in North American countries. However, the Asia Pacific is considered the most lucrative market for temperature management for the market players owing to the growing demand for aesthetic and medical surgeries, rising incidence of cardiac arrests and CNS disorders, government efforts to increase access to elective surgeries, and improving healthcare infrastructures. The market players are tapping these opportunities through the adoption of inorganic growth strategies such as agreements and partnerships and acquisitions.